DHR
Danaher Corporation
NYSE: DHR · HEALTHCARE · DIAGNOSTICS & RESEARCH
$178.95
+0.08% today
Updated 2026-04-29
Market cap
$126.55B
P/E ratio
34.58
P/S ratio
5.11x
EPS (TTM)
$5.17
Dividend yield
0.76%
52W range
$175 – $242
Volume
4.3M
Danaher Corporation (DHR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+6.9%
Last 4 quarters
Revenue YoY growth
+3.7%
Most recent quarter
EPS YoY growth
+9.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.7%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-6.8%
2026-01-28
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-21 | $2.06 | +6.2% | $195.50 | $184.04 | -5.9% |
| 2026-01-28 | $2.23 | +1.8% | $235.75 | $219.62 | -6.8% |
| 2025-10-21 | $1.89 | +9.9% | $208.39 | $218.10 | +4.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $1.94 | $2.06 | +6.2% | $5.95B | +3.7% |
| 2025-12-31 | $2.19 | $2.23 | +1.8% | $6.84B | +4.6% |
| 2025-09-30 | $1.72 | $1.89 | +9.9% | $6.05B | +4.4% |
| 2025-06-30 | $1.64 | $1.80 | +9.8% | $5.94B | +3.4% |
| 2025-03-31 | $1.64 | $1.88 | +14.6% | $5.74B | -0.9% |
| 2024-12-31 | $2.16 | $2.14 | -0.9% | $6.54B | +2.1% |
| 2024-09-30 | $1.57 | $1.71 | +8.9% | $5.80B | +3.1% |
| 2024-06-30 | $1.57 | $1.72 | +9.6% | $5.74B | — |
| 2024-03-31 | $1.71 | $1.92 | +12.3% | $5.80B | — |
| 2023-12-31 | $1.91 | $2.09 | +9.4% | $6.41B | — |
| 2023-09-30 | $1.88 | $2.02 | +7.4% | $5.62B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $8.49 | $26.9B | +9.4% | 15 | high |
| 2027 (E) | $9.21 | $28.6B | +6.5% | 15 | high |
| 2028 (E) | $10.05 | $30.6B | +6.6% | 15 | medium |
| 2029 (E) | $10.95 | $32.8B | +7.4% | 15 | medium |
| 2030 (E) | $11.85 | $35.2B | +7.3% | 15 | medium |
Frequently asked questions
Has Danaher Corporation beaten earnings estimates?
Danaher Corporation has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +6.9% over the last 4 quarters.
How does DHR stock react to earnings?
DHR stock has moved an average of -2.7% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Danaher Corporation's revenue growth rate?
Danaher Corporation reported year-over-year revenue growth of +3.7% in its most recent quarter, with EPS growing +9.6% year-over-year.
What is the expected EPS for DHR in 2026?
Analysts expect Danaher Corporation to report EPS of $8.49 for fiscal year 2026, on revenue of $26.9B, based on estimates from 15 analysts.